Neurological

Sitting Tai Chi Exercises Improve Recovery Outcomes for Older Stroke Survivors

Practicing sitting Tai Chi early after a stroke enhanced health outcomes, such as hand and arm function, sitting balance, and mental health.

Neurological

Study: Brain Implants Safe, May Help Those with Paralysis Use Computer for Daily Tasks

A brain-computer interface (aka brain implant) is safe and allows participants to use a computer to communicate by text and do daily tasks.

Neurological

Centre for Neuro Skills’ California Facilities Receive 3-Year CARF Accreditation

Centre for Neuro Skills' California facilities have been accredited for a period of 3 years by CARF International.

Biogen Announces New SMA Research Updates at 2022 MDA Conference

by Debbie Overman | Mar 15, 2022 | Association News, Muscular Dystrophy

Biogen Inc is presenting new data and updates from its SPINRAZA and spinal muscular atrophy research program at the 2022 MDA Clinical & Scientific Conference.

Fulcrum Therapeutics Presents Data Highlighting Reachable Workspace as Functional Endpoint in FSHD at MDA Conference

by Debbie Overman | Mar 15, 2022 | Muscular Dystrophy

Reachable Workspace can be used to assess FSHD progression and treatment response, Fulcrum Therapeutics shares.

ONWARD Medical’s LIFT Home Study Begins

by Debbie Overman | Mar 14, 2022 | Research, Spinal Cord Injury

The first patients have been enrolled in ONWARD’s LIFT HOME Study, designed to study the safety and performance of ARCEX Therapy when used in the home.

JOGO-Gx Shows Early Success in Treating Parkinson’s Disease Symptoms

by Debbie Overman | Mar 14, 2022 | Parkinson’s Disease

JOGO-Gx, a digital therapeutic that taps into the neuroplasticity of the brain using biofeedback, shows early success as a Parkinson’s treatment.

Christopher & Dana Reeve Foundation Marks 40 Years of Progress

by Debbie Overman | Mar 11, 2022 | Association News, Spinal Cord Injury

Originally created in 1982 in response to the injury of Henry Stifel, the Christopher & Dana Reeve Foundation marks its 40 anniversary.

Cellular Therapy Improves Signs, Symptoms of Duchenne

by Debbie Overman | Mar 11, 2022 | Muscular Dystrophy, Research

Cellular therapy helps stop the deterioration of upper limb and heart functions in Duchenne patients, clinical research suggests.

UT Health East Texas Rehab Hospital Earns Gold Seal of Approval

by Debbie Overman | Mar 10, 2022 | Stroke

UT Health East Texas Rehab Hospital receives Stroke Specific Rehabilitation Certification, it announces.

Lululemon Founder Commits $100 Million to Solve FSHD

by Debbie Overman | Mar 10, 2022 | Muscular Dystrophy

Chip Wilson has committed $100 million and created a new venture, Solve FSHD, with the objective of finding a cure for FSHD by 2027.

Parent Project Muscular Dystrophy Advocates Meet with Lawmakers to Request Support

by Debbie Overman | Mar 9, 2022 | Association News, Muscular Dystrophy

Advocates ask Congress to support scientific research funding and the BENEFIT Act.

PathMaker Neurosystems Initiates MyoRegulator Clinical Trial

by Debbie Overman | Mar 8, 2022 | Stroke

PathMaker Neurosystems Inc initiates a MyoRegulator clinical trial to evaluate the system to treat upper-limb spasticity.

Harnessing AI and Robotics to Treat Spinal Cord Injuries

by Debbie Overman | Mar 7, 2022 | Spinal Cord Injury

Using AI and robotics, researchers stabilized an enzyme able to degrade spinal cord injury scar tissue and promote tissue regeneration.

Adapt Concussion Protocols for Wheelchair Athletes, Per Blog

by Debbie Overman | Mar 7, 2022 | Traumatic Brain Injury

As the 2022 Paralympic Winter Games get underway in Beijing, this is a great time to be thinking about how the risks and management of concussion differ for parasport athletes, according to a blog post from Kenneth Lee, MD, in Healio Optometry.

Grant-Funded Research Project Aims to Deliver ‘Precision Medicine’ for Motor Neuron Disease

by Debbie Overman | Mar 3, 2022 | ALS, Research

A research program launched recently in Trinity College Dublin aims to provide new insights regarding Motor Neuron Disease, also known as ALS.

Adaptive HEALEY ALS Platform Trial Hopes to Bring New Treatments to Patients Faster

by Debbie Overman | Mar 3, 2022 | ALS

A study describes the approach, structure, and launch of the HEALEY ALS Platform Trial, designed to accelerate the development of treatments.

Cala Health Expands Affordable Access for Patients with Essential Tremor

by Debbie Overman | Mar 1, 2022 | Parkinson’s Disease

New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment for essential tremor, Cala Trio therapy, the company notes in a media release.

Category: Neurological

Neurological

Neurological

Neurological